Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.39 |
| ▸ | RELA | Q04206 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15400423 | 0.89 | ALDH1A1 (0.44) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL23780947 | 0.85 | ALDH1A1 (0.41) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL4979017 | 0.84 | HSD17B10 (0.48) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL15399698 | 0.81 | CDC25B (0.49) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL4232444 | 0.79 | ALDH1A1 (0.42) | MAPTALDH1A1HPGDTSHRHSD17B10 | |
| SCHEMBL27937819 | 0.78 | HSD11B1 (0.46) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL7862553 | 0.77 | KDM1A (0.55) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL11710361 | 0.77 | ALDH1A1 (0.39) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL6405547 | 0.77 | ABCG2 (0.48) | MAPTALDH1A1KDM4EHPGDTSHR | |
| SCHEMBL15511194 | 0.76 | ALDH1A1 (0.33) | MAPTALDH1A1KDM4EHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110240965-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-10-06 | — | — | US | claimed |
| US-7597967-B2 | Phosphorescent OLEDs with exciton blocking layer | EASTMAN KODAK COMPANY (US) | 2009-10-06 | — | — | US | claimed |
| EP-1701394-A1 | Organic electroluminescent device and method of manufacturing the same | Samsung SDI Co., Ltd. (KR) | 2006-09-13 | — | — | EP | claimed |
| US-20060199038-A1 | Organic electroluminescent device and method of manufacturing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2006-09-07 | — | — | US | claimed |
| US-20060134461-A1 | Organometallic materials and electroluminescent devices | EASTMAN KODAK COMPANY | 2006-06-22 | — | — | US | claimed |
| US-20060134460-A1 | Phosphorescent oleds with exciton blocking layer | GLOBAL OLED TECHNOLOGY LLC | 2006-06-22 | — | — | US | claimed |
| US-20060105201-A1 | Organic electroluminescent device | SAMSUNG DISPLAY CO., LTD. (KR) | 2006-05-18 | — | — | US | claimed |
| US-20050287393-A1 | Organic electroluminescent device | SAMSUNG SDI CO., LTD. (KR) | 2005-12-29 | — | — | US | claimed |
| EP-1610398-A2 | Organic electroluminescent device | Samsung SDI Co., Ltd. (KR) | 2005-12-28 | — | — | EP | claimed |
| EP-2984079-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2020-07-01 | — | — | EP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| EP-2243177-B1 | PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS | GLOBAL OLED TECHNOLOGY LLC (US) | 2019-05-15 | — | — | EP | disclosed |
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LIMITED (GB) | 2018-11-08 | — | — | US | disclosed |
| EP-2396801-B1 | OLED DEVICE WITH FLUORANTHENE-MACROCYCLIC MATERIALS | GLOBAL OLED TECHNOLOGY LLC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-20060199038-A1 | Organic electroluminescent device and method of manufacturing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2006-09-07 | — | — | US | disclosed |
| US-20060134461-A1 | Organometallic materials and electroluminescent devices | EASTMAN KODAK COMPANY | 2006-06-22 | — | — | US | disclosed |
| US-20060134460-A1 | Phosphorescent oleds with exciton blocking layer | GLOBAL OLED TECHNOLOGY LLC | 2006-06-22 | — | — | US | disclosed |
| US-20060105201-A1 | Organic electroluminescent device | SAMSUNG DISPLAY CO., LTD. (KR) | 2006-05-18 | — | — | US | disclosed |
| US-20050287393-A1 | Organic electroluminescent device | SAMSUNG SDI CO., LTD. (KR) | 2005-12-29 | — | — | US | disclosed |
| EP-1610398-A2 | Organic electroluminescent device | Samsung SDI Co., Ltd. (KR) | 2005-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180323378-A9 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | NAT1, SLCO2A1, SLCO2B1 | MAPT 1775/4885ALDH1A1 789/4885KDM4E 4166/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | MAPT 1775/4885ALDH1A1 789/4885KDM4E 4166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.